Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical imiquimod versus cidofovir for vulval intraepithelial neoplasia
ISRCTN34420460Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Jan 2008
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial in vulvar intraepithelial neoplasia (VIN) comparing Topical imiquimod with Topical cidofovir (2 arms). Primary endpoint: Histologically confirmed complete response. Started Jan 2008; status: completed.
02
Drugs
imiquimodcidofovir
03
Conditions
vulvar intraepithelial neoplasia (VIN)
Beyond the preview
Go deeper on ISRCTN34420460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34420460.